The impact of SARS-CoV-2 on small businesses and new ventures in the US has been profound and in some ways unpredictable. This presentation will highlight important chemically-related elements of two new ventures. The first of these is starting a new business focused on products containing cannabidiol. Such a business is heavily regulated at both the state and federal levels, thus incurring a myriad of considerations for both startup and interstate commerce. A second discussion will illustrate how COVID-19 has highlighted the issues and critical limitations of US manufacturing of active pharmaceutical ingredients and finished medicines.

Startup of new chemical manufacturing in the United States

ACS Fall 2021

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.